Lunch & Learn with RoukenBio
Join us for an in-person Lunch and Learn with RoukenBio on 25th November at the Visitors Suite, Innovation Gateway!
Many cancer treatments work by finding a specific marker on cancer cells, and how much of that marker a cell has can decide whether a treatment works. RoukenBio’s IndEx-2 lets scientists turn marker levels up or down like a dimmer switch, showing exactly how much a treatment needs to work and helping predict which patients are most likely to benefit.
Open to Innovation Gateway tenants and the wider London Cancer District community, this is a relaxed chance to hear about cutting-edge cancer research and connect with others across the ecosystem. Lunch provided, curiosity encouraged.
Book Now
On Wednesday 25th November between 12:00-13:00, hear from RoukenBio about IndEx-2, their new platform that helps scientists see exactly how much of a cancer marker a treatment needs to work, and how it’s speeding up the development of new cancer therapies.